[1] |
江红,吴永健.阿托伐他汀治疗新进展[J].心血管病学进展,2004(5):335.
|
[2] |
丁洪,吴林森,陈永乐.四种半合成及全合成他汀类药物的研究与开发[J].药学进展,1999(2):65.
|
[3] |
KUMAR Y,KUMAR SMD,SATHYANARAYANA S.Process for the production of atorvastatin calcium in amorphous form:20090216029[P].2009-08-27.
|
[4] |
杨宽,余丽丽,姚琳,等.调血脂药物阿伐他汀的合成路线[J].化工科技,2013(4):71.
|
[5] |
MOTHANA B,BOYD R J.A density functional theory study of the mechanism of the Paal-Knorr pyrrole synthesis[J].Journal of Molecular Structure Theo Chem,2007,811(1-3):97.
|
[6] |
金勇,吴坚平,徐刚,等.有机相酶催化氨解反应拆分制备(R)-4-氯-3-羟基丁酸乙酯[J].有机化学,2006(10):1384.
|
[7] |
钟萍,孙志浩.生物催化不对称还原方法生产(S)-4-氯-3-羟基丁酸乙酯[J].过程工程学报,2005(6):665.
|
[8] |
LEE H W,KIM Y M,YOO C L,et al.An efficient method for the large-scale synthesis of atorvastatin calcium[J].Biomolecules & Therapeutics,2008,16(1):28.
|
[9] |
DESANTIS G,WONG K,FARWELL B,et al.Creation of a productive,highly enantioselective nitrilase through gene site saturation mutagenesis (GSSM)[J].Journal of the Hmerican Chemical Society,2003,125(38):11476.
|
[10] |
WANG L J,LI C X,NI Y,et al.Highly efficient synthesis of chiral alcohols with a novel NADH-dependent reductase from Streptomyces coelicolor[J].Biovesource Technology,2011,102(14):7023.
|
[11] |
何玉财,陶志成,张丹平,等.(R)-4-氯-3-羟基丁酸乙酯及其衍生物的生物合成方法:104988085[P].2015-10-21.
|
[12] |
曹林秋.载体固定化酶:原理、应用和设计[M].北京:化学工业出版社,2008.
|
[13] |
OGINO C,NEGI Y,MATSUMIYA T,et al.Purification,characterization and sequence determination of phospholipase D secreted by streptoverticillium cinnamoneum[J].Journal of Biochemistry,1999,125(2):263.
|
[14] |
WANG G J,HOLLINGSWORTH R I.Synthetic routes to l-carnitine and l-gamma-amino-beta-hydroxybutyric acid from (S)-3-hydroxybutyrolactone by functional group priority switching[J].Tetrahedron Asymmetr,1999,10(10):1895.
|